Biovotec Limited Is Expanding The Core Team
After the foundation of Biovotec Ltd in Dublin and the appointment of Enda Kenny as the Managing Director, the company has now brought on two highly experienced professionals. They enter the company with together more than 30 years experience in the MedTech industry and with very relevant background of developing and CE marking comparable products
“We are very pleased to be able to attract such talent as Paul Barham and Irene Cleary. They enter the company in a critical period where we transform from purely research to product development and finally product launch. They both have experience from companies which have taken this journey successfully. This hands on experience cannot be overstated.” - Ralf Schmidt, CEO at Biovotec
Paul Barham has a Masters degree in Biotechnology for the City University in Dublin. He has worked more than 18 years in the field of Biotechnology, Medical Device and Pharmaceutical Industry. He has been part of several successful product launches where he had a key role in product development and building up production capabilities. He brings with him an extensive knowledge of GMP and CE marking processes. In the latest years he has worked with collagen based products.
“Paul’s extensive knowledge of collagen based products will allow us to explore alternative applications of our raw material: eggshell membrane, while at the same time accelerating the development of our lead product for chronic wound care.” - Ralf Schmidt, CEO at Biovotec
Irene Cleary has a PhD from the National Cell & Tissue Centre in Dublin. She has worked over 15 years in the Biopharmaceutical and Medical Device industries, both within R&D and Product Development. In the later years she has worked with quality assurance and is a Certified Person to conduct and lead quality audits. She also has extensive knowledge of tissue engineering which is the basis for wound care.
“The knowledge within the field of tissue engineering, quality assurance and CE mark processes is a rare combination. We are very pleased to have attracted Irene to assist us in these areas which are critical for the success of Biovotec.” - Ralf Schmidt, CEO at Biovotec